metricas
Revista Española de Anestesiología y Reanimación (English Edition) Perioperative neuromuscular blockade. 2020 update of the SEDAR (Sociedad Españo...
Journal Information
Vol. 70. Issue 1.
Pages 1-64 (January 2023)
Cite
Cite
Share
Download PDF
More article options
Visits
1639
Vol. 70. Issue 1.
Pages 1-64 (January 2023)
CONSENSUS STATEMENT

Perioperative neuromuscular blockade. 2020 update of the SEDAR (Sociedad Española de Anestesiología y Reanimación) recommendations

Bloqueo neuromuscular perioperatorio. Actualización 2020 de las Recomendaciones de la Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor (SEDAR)
Visits
1639
O. Díaz-Cambroneroa, A. Serranob, A. Abad-Gurumetac, I. Garutti Martinezd, N. Estevee, E. Aldayf, C. Ferrandog, G. Mazzinaria, P. Vila-Caralh, C.L. Errando Oyonartei,
Corresponding author
, Grupo de Trabajo de Bloqueo Neuromuscular de la SEDAR
a Hospital Universitari Politécnic La Fe, Grupo de Investigación Medicina Perioperatoria, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
b Hospital Ramón y Cajal, Madrid, Spain
c Hospital Universitario Infanta Leonor, Madrid, Spain
d Hospital Universitario Gregorio Marañón, Madrid, Spain
e Hospital Son Espases, Palma de Mallorca, Mallorca, Spain
f Hospital de La Princesa, Madrid, Spain
g Hospital Clínic, Barcelona, Spain
h Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
i Hospital Can Misses, Ibiza, Islas Baleares, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
Ver más
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract

We present an update of the 2020 Recommendations on neuromuscular blockade of the SEDAR. The previous ones dated 2009. A modified Delphi consensus analysis (experts, working group, and previous extensive bibliographic revision) 10 recommendations were produced1: neuromuscular blocking agents were recommended for endotracheal intubation and to avoid faringo-laryngeal and tracheal lesions, including critical care patients.2 We recommend not to use neuromuscular blocking agents for routine insertion of supraglotic airway devices, and to use it only in cases of airway obstruction or endotracheal intubation through the device.3 We recommend to use a rapid action neuromuscular blocking agent with an hypnotic in rapid sequence induction of anesthesia.4 We recommend profound neuromuscular block in laparoscopic surgery.5 We recommend quantitative monitoring of neuromuscular blockade during the whole surgical procedure, provided neuromuscular blocking agents have been used.6 We recommend quantitative monitoring through ulnar nerve stimulation and response evaluation of the adductor pollicis brevis, acceleromyography being the clinical standard.7 We recommend a recovery of neuromuscular block of at least TOFr ≥ 0.9 to avoid postoperative residual neuromuscular blockade.8 We recommend drug reversal of neuromuscular block at the end of general anesthetic, before extubation, provided a TOFr ≥ 0.9 has not been reached.9 We recommend to choose anticholinesterases for neuromuscular block reversal only if TOF≥2 and a TOFr ≥ 0.9 has not been attained.10 We recommend to choose sugammadex instead of anticholinesterases for reversal of neuromuscular blockade induced with rocuronium.

Keywords:
Muscle relaxants
Neuromuscular blocking agents
Anesthesia
Perioperative period
Resumen

Se presenta la actualización 2020 de las Recomendaciones de bloqueo neuromuscular de la SEDAR. Las anteriores databan de 2009. Tras un análisis de consenso Delphi (expertos, grupo de trabajo y revisión bibliográfica previa) se generaron 10 recomendaciones1: Se recomienda el uso de fármacos bloqueantes neuromusculares para facilitar la intubación traqueal y evitar lesiones faringo-laringo-traqueales en cualquier paciente, incluidos pacientes críticos.2 Se recomienda no utilizar fármacos bloqueantes neuromusculares para la inserción rutinaria de dispositivos supraglóticos y utilizar solo en caso de obstrucción de la vía aérea o intubación traqueal a través de éste.3 Se recomienda utilizar un fármaco bloqueante neuromuscular de inicio de acción rápido asociado al agente hipnótico en la inducción de secuencia rápida.4 Se recomienda utilizar un nivel de bloqueo neuromuscular profundo en cirugía laparoscópica.5 Se recomienda el uso de monitorización cuantitativa del bloqueo neuromuscular durante todo el procedimiento quirúrgico, siempre que se utilicen fármacos bloqueantes neuromusculares.6 Se recomienda la monitorización cuantitativa mediante estimulación del nervio cubital y evaluación de la respuesta en el músculo aductor corto del pulgar, siendo el estándar clínico la aceleromiografía.7 Se recomienda una recuperación del bloqueo neuromuscular al menos hasta alcanzar un TOFr ≥ 0,9 para evitar el bloqueo neuromuscular residual postoperatorio.8 Se recomienda la reversión farmacológica del bloqueo neuromuscular al finalizar la anestesia general, previo a la extubación traqueal siempre que no se haya alcanzado un TOFr ≥ 0,9.9 Se recomienda utilizar fármacos anticolinesterásicos para la reversión del bloqueo neuromuscular solo cuando TOF≥2 y no se haya alcanzado un TOFr ≥ 0,9.10 Se recomienda utilizar sugammadex frente a fármacos anticolinesterásicos para la reversión del bloqueo neuromuscular con rocuronio.

Palabras clave:
Relajantes musculares
Bloqueantes neuromusculares
Anestesia
Perioperatorio

Article

These are the options to access the full texts of the publication Revista Española de Anestesiología y Reanimación (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
C.L. Errando.
[Neuromuscular blockers. Residual neuromuscular blockade. Monitoring. Pharmacologic reversion. Update].
Rev Esp Anest Reanim, 58 (2011), pp. 1-3
[2]
T. Fuchs-Buder.
Neuromuscular monitoring in clinical practice and research.
Springer, (2010),
[3]
J. Alvarez-Gomez, G. Veiga-Ruiz.
[Sugammadex: a new approach to the use of neuromuscular blockers].
Rev Esp Anestesiol Reanim, 58 (2011), pp. 20-23
[4]
C. Batistaki, K. Vagdatli, A. Tsiotou, A. Papaioannou, A. Pandazi, P. Matsota.
A multicenter survey on the use of neuromuscular blockade in Greece. Does the real-world clinical practice indicate the necessity of guidelines?.
J Anaesthesiol Clin Pharmacol, 35 (2019), pp. 202-214
[5]
G.A. Eapen, A.M. Shah, X. Lei, C.A. Jimenez, R.C. Morice, L. Yarmus, et al.
Complications, consequences, and practice patterns of endobronchial ultrasound-guided transbronchial needle aspiration: results of the AQuIRE registry.
Chest, 143 (2013), pp. 1044-1053
[6]
A. Higgs, B.A. McGrath, C. Goddard, J. Rangasami, G. Suntharalingam, R. Gale, et al.
DAS guidelines on the airway management of critically ill patients.
Anaesthesia, 73 (2018), pp. 1035-1036
[7]
A. Higgs, B.A. McGrath, C. Goddard, J. Rangasami, G. Suntharalingam, R. Gale, et al.
Guidelines for the management of tracheal intubation in critically ill adults.
Br J Anaesth, 120 (2018), pp. 323-352
[8]
A.G. Jensen, T. Callesen, J.S. Hagemo, K. Hreinsson, V. Lund, J. Nordmark, et al.
Scandinavian clinical practice guidelines on general anaesthesia for emergency situations.
Acta Anaesthesiol Scand, 54 (2010), pp. 922-950
[9]
B. Plaud, C. Baillard, J.L. Bourgain, K. Hreinsson, V. Lund, J. Nordmark, et al.
Guidelines on muscle relaxants and reversal in anaesthesia.
Anaesth Crit Care Pain Med, 39 (2020), pp. 125-142
[10]
M.R. Checketts, R. Alladi, K. Ferguson, L. Gemmell, J.M. Handy, A.A. Klein, et al.
Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland.
Anaesthesia, 71 (2016), pp. 85-93
[11]
C. Eichelsbacher, H. Ilper, R. Noppens, J. Hinkelbein, T. Loop.
[Rapid sequence induction and intubation in patients with risk of aspiration: recommendations for action for practical management of anesthesia].
Der Anaesthesist, 67 (2018), pp. 568-583
[12]
C.L. Errando-Oyonarte, C. Moreno-Sanz, P. Vila-Caral, J.C. Ruiz de Adana-Belbel, E. Vazquez-Alonso, J.M. Ramirez-Rodriguez, et al.
Recommendations on the use of deep neuromuscular blockade by anaesthesiologists and surgeons. AQUILES (Anestesia QUIrurgica para Lograr Eficiencia y Seguridad) Consensus.
Rev Esp Anestesiol Reanim, 64 (2017), pp. 95-104
[13]
C.A. Lien, A.F. Kopman.
Current recommendations for monitoring depth of neuromuscular blockade.
Curr Opinion Anaesthesiol, 27 (2014), pp. 616-622
[14]
W.A. Wetsch, J. Hinkelbein.
Current national recommendations on rapid sequence induction in Europe. How standardised is the’ standard of care’?.
Eur J Anaesthesiol, 31 (2014), pp. 443-444
[15]
J.A. Alvarez Gomez, J.J. Arino Irujo, C.L. Errando Oyonarte, F. Matinez Torrente, J. Roige i Sole, F. Gilsanz Rodriguez.
[Use of neuromuscular blocking agents and reversal of blockade: guidelines from Sociedad Espanola de Anestesiologia, Reanimacion y Terapeutica del Dolor].
Rev Esp Anestesiol Reanim, 56 (2009), pp. 616-627
[16]
K. El-Boghdadly, C.R. Bailey, M.D. Wiles.
Postoperative sore throat: a systematic review.
Anaesthesia, 71 (2016), pp. 706-717
[17]
X. Combes, L. Andriamifidy, E. Dufresne, P. Suen, S. Sauvat, E. Scherrer, et al.
Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort.
Br J Anaesth, 99 (2007), pp. 276-281
[18]
P. Baker.
Mask ventilation.
[19]
S. Maitra, P. Khanna, D.K. Baidya.
Comparison of laryngeal mask airway Supreme and laryngeal mask airway Pro-Seal for controlled ventilation during general anaesthesia in adult patients: systematic review with meta-analysis.
Eur J Anaesthesiol, 31 (2014), pp. 266-273
[20]
T.M. Hemmerling, P. Beaulieu, K.E. Jacobi, D. Babin, J. Schmidt.
Neuromuscular blockade does not change the incidence or severity of pharyngolaryngeal discomfort after LMA anesthesia.
Can J Anesth, 51 (2004), pp. 728-732
[21]
M. Fujimoto, F. Kubota, T. Yamamoto.
The effect of rocuronium on ventilatory leak and sealing pressure using a supraglottic airway device: a randomized clinical trial.
Acta Anaesthesiol Scand, 64 (2020), pp. 1120-1127
[22]
J. Klucka, M. Kosinova, K. Zacharowski, S. De Hert, M. Kratochvil, M. Toukalkova, et al.
Rapid sequence induction: an international survey.
Eur J Anaesthesiol, 37 (2020), pp. 435-442
[23]
J.J. Perry, J.S. Lee, V.A. Sillberg, G.A. Wells.
Rocuronium versus succinylcholine for rapid sequence induction intubation.
Cochrane Database Syst Rev, (2008),
[24]
M. Sorensen, C. Bretlau, M. Gatke, A. Sorensen, L. Rasmussen.
Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine: a randomized trial.
Br J Anaesth, 108 (2012), pp. 682-689
[25]
L. Tang, S. Li, S. Huang, H. Ma, Z. Wang.
Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients.
Acta Anaesthesiol Scand, 55 (2011), pp. 203-208
[26]
S.K. Taha, M.F. El-Khatib, A.S. Baraka, Y.A. Haidar, F.W. Abdallah, R.A. Zbeidy, et al.
Effect of suxamethonium vs rocuronium on onset of oxygen desaturation during apnoea following rapid sequence induction.
Anaesthesia, 65 (2010), pp. 358-361
[27]
A.Y. Oh, S.J. Cho, K.S. Seo, J.H. Ryu, S.H. Han, J.W. Hwang.
Dose of rocuronium for rapid tracheal intubation following remifentanil 2 mug kg-1 and propofol 2 mg kg-1.
Eur J Anaesthesiol, 30 (2013), pp. 550-555
[28]
D.T.T. Tran, E.K. Newton, V.A.H. Mount, J.S. Lee, C. Mansour, G.A. Wells, et al.
Rocuronium vs. succinylcholine for rapid sequence intubation: a Cochrane systematic review.
Anaesthesia, 72 (2017), pp. 765-777
[29]
J.L. Stollings, D.A. Diedrich, L.J. Oyen, D.R. Brown.
Rapid-sequence intubation: a review of the process and considerations when choosing medications.
Ann Pharmacother, 48 (2014), pp. 62-76
[30]
J.A. Sastre, T. Lopez, M.A. Gomez-Rios, J.C. Garzon, M.L. Mariscal, E. Martinez-Hurtado, et al.
Current practice of rapid sequence induction in adults: a national survey among anesthesiologists in Spain.
Rev Esp Anestesiol Reanim, 67 (2020), pp. 381-390
[31]
P. Stourac, M. Adamus, D. Seidlova, T. Pavlik, P. Janku, I. Krikava, et al.
Low-dose or high-dose rocuronium reversed with neostigmine or sugammadex for cesarean delivery anesthesia: a randomized controlled noninferiority trial of time to tracheal intubation and extubation.
Anesth Analg, 122 (2016), pp. 1536-1545
[32]
M. Kosinova, P. Stourac, M. Adamus, D. Seidlova, T. Pavlik, P. Janku, et al.
Rocuronium versus suxamethonium for rapid sequence induction of general anaesthesia for caesarean section: influence on neonatal outcomes.
Int J Obstet Anesth, 32 (2017), pp. 4-10
[33]
B. Guihard, C. Chollet-Xemard, P. Lakhnati, B. Vivien, C. Broche, D. Savary, et al.
Effect of rocuronium vs succinylcholine on endotracheal intubation success rate among patients undergoing out-of-hospital rapid sequence intubation: a randomized clinical trial.
JAMA, 322 (2019), pp. 2303-2312
[34]
M.H. Bruintjes, E.V. van Helden, A.E. Braat, A. Dahan, G.J. Scheffer, C.J. van Laarhoven, et al.
Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis.
Br J Anaesth, 118 (2017), pp. 834-842
[35]
S.K. Park, Y.G. Son, S. Yoo, T. Lim, W.H. Kim, J.T. Kim.
Deep vs. moderate neuromuscular blockade during laparoscopic surgery: a systematic review and meta-analysis.
Eur J Anaesthesiol, 35 (2018), pp. 867-875
[36]
D.M. Ozdemir-van Brunschot, K.C. van Laarhoven, G.J. Scheffer, S. Pouwels, K.E. Wever, M.C. Warle.
What is the evidence for the use of low-pressure pneumoperitoneum? A systematic review.
Surg Endosc, 30 (2016), pp. 2049-2065
[37]
M.V. Madsen, O. Istre, A.K. Staehr-Rye, H.H. Springborg, J. Rosenberg, J. Lund, et al.
Postoperative shoulder pain after laparoscopic hysterectomy with deep neuromuscular blockade and low-pressure pneumoperitoneum: a randomised controlled trial.
Eur J Anaesthesiol, 33 (2016), pp. 341-347
[38]
J. Barrio, C.L. Errando, J. Garcia-Ramon, R. Selles, G. San Miguel, J. Gallego.
Influence of depth of neuromuscular blockade on surgical conditions during low-pressure pneumoperitoneum laparoscopic cholecystectomy: a randomized blinded study.
J Clin Anesth, 42 (2017), pp. 26-30
[39]
O. Diaz-Cambronero, G. Mazzinari, B. Flor Lorente, N. Garcia Gregorio, D. Robles-Hernandez, L.E. Olmedilla Arnal, et al.
Effect of an individualized versus standard pneumoperitoneum pressure strategy on postoperative recovery: a randomized clinical trial in laparoscopic colorectal surgery.
[40]
J. Barrio, C.L. Errando, G. San Miguel, B.I. Salas, J. Raga, J.L. Carrion, et al.
Effect of depth of neuromuscular blockade on the abdominal space during pneumoperitoneum establishment in laparoscopic surgery.
J Clin Anesth, 34 (2016), pp. 197-203
[41]
M.V. Madsen, A.K. Staehr-Rye, M.R. Gatke, C. Claudius.
Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review.
Acta Anaesthesiol Scand, 59 (2015), pp. 1-16
[42]
M.V. Madsen, S. Scheppan, E. Mork, P. Kissmeyer, J. Rosenberg, M.R. Gatke.
Influence of deep neuromuscular block on the surgeons assessment of surgical conditions during laparotomy: a randomized controlled double blinded trial with rocuronium and sugammadex.
Br J Anaesth, 119 (2017), pp. 1247
[43]
T. Fuchs-Buder, E. De Robertis, L. Brunaud.
Neuromuscular block in laparoscopic surgery.
Minerva Anestesiol, 84 (2018), pp. 509-514
[44]
H. Carvalho, M. Verdonck, W. Cools, L. Geerts, P. Forget, J. Poelaert.
Forty years of neuromuscular monitoring and postoperative residual curarisation: a meta-analysis and evaluation of confidence in network meta-analysis.
Br J Anaesth, 125 (2020), pp. 466-482
[45]
G. Cammu.
Residual neuromuscular blockade and postoperative pulmonary complications: what does the recent evidence demonstrate?.
Curr Anesthesiol Rep, (2020), pp. 1-6
[46]
M. Naguib, S.J. Brull, J.M. Hunter, A.F. Kopman, B. Fulesdi, K.B. Johnson, et al.
Anesthesiologists’ overconfidence in their perceived knowledge of neuromuscular monitoring and its relevance to all aspects of medical practice: an international survey.
Anesth Analg, 128 (2018), pp. 1118-1126
[47]
M. Naguib, S.J. Brull, A.F. Kopman, J.M. Hunter, B. Fulesdi, H.R. Arkes, et al.
Consensus statement on perioperative use of neuromuscular monitoring.
Anesth Analg, 127 (2018), pp. 71-80
[48]
G.S. Murphy.
Neuromuscular monitoring in the perioperative period.
Anesth Analg, 126 (2018), pp. 464-468
[49]
S.J. Brull, A.F. Kopman.
Current status of neuromuscular reversal and monitoring: challenges and opportunities.
Anesthesiology, 126 (2017), pp. 173-190
[50]
M. Naguib, S.J. Brull, K.B. Johnson.
Conceptual and technical insights into the basis of neuromuscular monitoring.
Anaesthesia, 72 (2017), pp. 16-37
[51]
C.L. Errando, I. Garutti, G. Mazzinari, O. Diaz-Cambronero, J.F. Bebawy.
Grupo Español De Estudio Del Bloqueo Neuromuscular Residual. Neuromuscular blockade in the postanesthesia care unit: observational cross-sectional study of a multicenter cohort.
Minerva Anestesiol, 82 (2016), pp. 1267-1277
[52]
E. Kirmeier, L.I. Eriksson, H. Lewald, M. Jonsson Fagerlund, A. Hoeft, M. Hollmann, et al.
Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study.
Lancet Respir Med, 7 (2019), pp. 129-140
[53]
G. Mazzinari, C.L. Errando, O. Diaz-Cambronero, M. Martin-Flores.
Influence of tetanic stimulation on the staircase phenomenon and the acceleromyographic time-course of neuromuscular block: a randomized controlled trial.
J Clin Monit Comput, 33 (2018), pp. 325-332
[54]
C. Ferrando, M. Soro, C. Unzueta, F. Suarez-Sipmann, J. Canet, J. Librero, et al.
Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial.
Lancet Respir Med, 6 (2018), pp. 193-203
[55]
M. Eikermann, H. Groeben, J. Husing, J. Peters.
Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade.
Anesthesiology, 98 (2003), pp. 1333-1337
[56]
I. Garutti, C.L. Errando, G. Mazzinari, J.M. Bellon, O. Diaz-Cambronero, C. Ferrando, et al.
Spontaneous recovery of neuromuscular blockade is an independent risk factor for postoperative pulmonary complications after abdominal surgery: a secondary analysis.
Eur J Anaesthesiol, 37 (2020), pp. 203-211
[57]
M. Blobner, J.M. Hunter, C. Meistelman, A. Hoeft, M.W. Hollmann, E. Kirmeier, et al.
Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data.
Br J Anaesth, 124 (2020), pp. 63-72
[58]
L.P. Fortier, D. McKeen, K. Turner, E. de Medicis, B. Warriner, P.M. Jones, et al.
The RECITE Study: a Canadian prospective, multicenter study of the incidence and severity of residual neuromuscular blockade.
Anesth Analg, 121 (2015), pp. 366-372
[59]
E. Alday, M. Munoz, A. Planas, E. Mata, C. Alvarez.
Effects of neuromuscular block reversal with sugammadex versus neostigmine on postoperative respiratory outcomes after major abdominal surgery: a randomized-controlled trial.
Can J Anaesth, 66 (2019), pp. 1328-1337
[60]
C.M. Bulka, M.A. Terekhov, B.J. Martin, R.R. Dmochowski, R.M. Hayes, J.M. Ehrenfeld.
Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia.
Anesthesiology, 125 (2016), pp. 647-655
[61]
M.R. Bronsert, W.G. Henderson, T.G. Monk, J.S. Richman, J.D. Nguyen, J.T. Sum-Ping, et al.
Intermediate-acting nondepolarizing neuromuscular blocking agents and risk of postoperative 30-day morbidity and mortality, and long-term survival.
Anesth Analg, 124 (2017), pp. 1476-1483
[62]
T. Schepens, K. Janssens, S. Maes, D. Wildemeersch, J. Vellinga, P.G. Jorens, et al.
Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.
BMC Anesthesiol, 19 (2019), pp. 187
[63]
K.R. Hafeez, A. Tuteja, M. Singh, D.T. Wong, M. Nagappa, F. Chung, et al.
Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review.
BMC Anesthesiol, 18 (2018), pp. 91
[64]
M. Carron, F. Zarantonello, P. Tellaroli, C. Ori.
Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
J Clin Anesth, 35 (2016), pp. 1-12
[65]
N. Deyhim, A. Beck, J. Balk, M.G. Liebl.
Impact of sugammadex versus neostigmine/glycopyrrolate on perioperative efficiency.
Clinicoecon Outcomes Res, 12 (2020), pp. 69-79
[66]
T.K. Oh, J.H. Ryu, S. Nam, A.Y. Oh.
Association of neuromuscular reversal by sugammadex and neostigmine with 90-day mortality after non-cardiac surgery.
BMC Anesthesiol, 20 (2020), pp. 41
[67]
A.M. Hristovska, P. Duch, M. Allingstrup, A. Afshari.
The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis.
Anaesthesia, 73 (2018), pp. 631-641
[68]
M. Carron, F. Zarantonello, N. Lazzarotto, P. Tellaroli, C. Ori.
Role of sugammadex in accelerating postoperative discharge: a meta-analysis.
J Clin Anesth, 39 (2017), pp. 38-44
[69]
A. Abad-Gurumeta, J. Ripolles-Melchor, R. Casans-Frances, A. Espinosa, E. Martinez-Hurtado, C. Fernandez-Perez, et al.
A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade.
Anaesthesia, 70 (2015), pp. 1441-1452
[70]
N. Tajaate, J.U. Schreiber, T. Fuchs-Buder, Y. Jelting, P. Kranke.
Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: a systematic review.
Eur J Anaesthesiol, 35 (2018), pp. 184-192
[71]
J.M. Hunter.
Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation.
Br J Anaesth, 119 (2017), pp. i53-i62
[72]
K. Leslie.
Sugammadex and postoperative pulmonary complications: is stronger evidence required?.
Anesthesiology, 132 (2020), pp. 1299-1300
[73]
S. Kheterpal, M.T. Vaughn, T.Z. Dubovoy, N.J. Shah, L.D. Bash, D.A. Colquhoun, et al.
Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis.
Anesthesiology, 132 (2020), pp. 1371-1381
[74]
M. Krause, S.K. McWilliams, K.J. Bullard, L.M. Mayes, L.C. Jameson, S.K. Mikulich-Gilbertson, et al.
Neostigmine versus sugammadex for reversal of neuromuscular blockade and effects on reintubation for respiratory failure or newly initiated noninvasive ventilation: an interrupted time series design.
Anesth Analg, 131 (2020), pp. 141-151
[75]
A.D. Raval, S. Deshpande, S. Rabar, M. Koufopoulou, B. Neupane, I. Iheanacho, et al.
Does deep neuromuscular blockade during laparoscopy procedures change patient, surgical, and healthcare resource outcomes? A systematic review and meta-analysis of randomized controlled trials.
[76]
A.D. Raval, V.R. Anupindi, C.P. Ferrufino, D.L. Arper, L.D. Bash, S.J. Brull.
Epidemiology and outcomes of residual neuromuscular blockade: a systematic review of observational studies.
asdasdasd
Article options
Tools
Supplemental materials